Press release
Global Bi-Specific MAbS Market: Focus on Rapid Browth, Driving Factors and Principal trends
Bi-Specific MAbS Market Size
What Is The Projected Market Size Of The Global Bi-Specific MAbS Market And Its Growth Rate?
The Bi-Specific MAbS market promises substantial growth, with the market set to grow from $7.83 billion in 2024 to a staggering $15.19 billion in 2029. Attributes for this growth include increased healthcare expenditure, technological advancements, and a rise in chronic diseases.
• 2024 Market Size: $7.83 billion
• 2025 Forecasted Market Size: $9.1 billion (16.2% CAGR)
• 2029 Forecasted Market Size: $15.19 billion (13.7% CAGR)
What Is Driving The Growth In The Bi-Specific MAbS Market?
The primary driver can be attributed to the rise in the prevalence of cancer and other chronic diseases, thus necessitating the need for bi-specific monoclonal antibodies. These antibodies are more effective than monoclonal antibodies as they target two or more tumor antigens on cells, therefore disrupting cancer progression. A substantial number of these chronic diseases, including cancer, are forecasted to fuel the demand for bi-specific MAbs to treat these effectively.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3390&type=smp
Who Are The Key Players Driving Bi-Specific MAbS Market Growth?
Significant organizations in the market include:
• F. Hoffmann-La Roche AG
• Amgen Inc
• Johnson & Johnson
• Sino Biological Inc
• Kyowa Kirin
• Zai Lab
• Alphamab Oncology
• Celldex Therapeutics
• Biocon
What Are The Key Trends In The Bi-Specific MAbS Market?
Notable trends in the market encompass:
• Technological advancements
• Product innovation
• Focus on artificial intelligence
• Investment in targeted and combination therapy
• Strategic partnerships
What Are The Segments Of The Global Bi-Specific MAbS Market?
The market segments incorporate:
1) By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab
2) By Product Type: In Vivo, In Vitro
3) By Indication: Cancer, Haemophilia A, Ophthalmic
4) By End Use: Hospitals, Research Institutes, Other End-Users
Which Region Leads The Bi-Specific MAbS Market?
North America leads the charge in the Bi-Specific MAbs market, holding the top spot in 2024. Other regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/bi-specific-mab-global-market-report
What Is Covered In The Bi-Specific MAbS Market Global Market Report?
- Market Size Analysis: Analyze the Bi-Specific MAbS Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Bi-Specific MAbS Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Bi-Specific MAbS Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Bi-Specific MAbS Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=3390&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Bi-Specific MAbS Market: Focus on Rapid Browth, Driving Factors and Principal trends here
News-ID: 3836316 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for MAbS
Emerging Anti-Cancer MAbS Market Trends: Product Innovations Drive Advancements …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Anti-Cancer MAbS Market Size Growth Forecast: What to Expect by 2025?
The market size of anti-cancer MAbS has seen considerable growth recently. It is projected to climb from $65.35 billion in 2024 to $71.25 billion by 2025, with a compound annual growth rate (CAGR) of 9.0%. Several factors have…
Bi-Specific MAbS Market Trends That Will Shape the Next Decade: Insights from St …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Bi-Specific MAbS Market Size By 2025?
The size of the bi-specific MAbS market has witnessed rapid expansion in the past few years. The estimation is that the market will surge from $7.83 billion in 2024 to $9.05 billion in 2025, with a compound annual growth…
Rising Global Cancer Prevalence Fuels Anticancer Monoclonal Antibodies (MABS) Ma …
The Anti-Cancer MAbS Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Cancer MAbS Market Size and Projected Growth Rate?
The anti-cancer mAbs market size has grown rapidly in recent years. It will increase from $69.33 billion in 2024 to $76.92 billion in 2025…
Key Anti-Cancer MAbS Market Trend for 2025-2034: Product Innovations Drive Advan …
What Is the Future Outlook for the Anti-Cancer MAbS Market's Size and Growth Rate?
There has been a swift expansion in the size of the anti-cancer mabs market in the past few years. The market's growth is expected to jump from $69.33 billion in 2024 to $76.92 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.0%. Factors contributing to this growth during the historical period include a rise…
Anti-Cancer MAbS Market Size, Share, Statistics - 2033
The new report published by The Business Research Company, titled ""Anti-Cancer MAbS Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the anti-cancer mabs market size has grown rapidly in recent years. It will grow from $59.98 billion in 2023…
Monoclonal Antibody (mABs) Therapeutics Market worth $497.5 billion by 2029
Monoclonal Antibody (mABs) Therapeutics market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a latest report published by MarketsandMarkets Trademark
Monoclonal Antibody (mABs) Therapeutics Market [https://www.marketsandmarkets.com/Market-Reports/monoclonal-antibody-mabs-therapeutics-market-115323820.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach…
